[1] MONTALVÁ E,RODRÍGUEZ-PERÁLVAREZ M,BLASI A,et al.Consensus statement on hemostatic management,anticoagulation,and antiplatelet therapy in liver transplantation[J].Transplantation,2022,106(6):1123-1131.
[2] ZANETTO A,NORTHUP P,ROBERTS L,et al.Haemostas is in cirrhosis:understanding destabilising factors during acute decompensation[J].J Hepatol,2023,78(5):1037-1047.
[3] 张华鹏,张嘉凯,胡博文.成人肝移植受者围术期凝血功能管理专家共识(2021版)[J].实用器官移植电子杂志,2021,9(2):89-94.
[4] PATRICK N,BETHANY R.Management of coagulation and anticoagulation in liver transplantation candidates[J].Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc,2018,24(8):1119-1132.
[5] TANAKA K A,SHETTAR S,VANDYCK K,et al.Roles of four-factor prothrombin complex concentrate in the management of critical bleeding[J].Transfus Med Rev,2021,35(4):96-103.
[6] REFAAI M A,GOLDSTEIN J N,LEE M L,et al.Increase d risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal[J].Transfusion,2015,55(11):2722-2729.
[7] VAN DIEVOET M A,STEPHENNE X,ROUSSEAUX M,et al.The use of prothrombin complex concentrate in chronic liver disease:a review of the literature[J].Transfus Med,2023,33(3):205-212.
[8] ERDOES G,KOSTER A,ORTMANN E,et al.A Europea n consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients[J].Anaesthesia,2021,76(3):381-392.
[9] HUDA S A,KAHLOWN S,JILANI M H,et al.Managemen t of life-threatening bleeding in patients with mechanical heart valves[J].Cureus,2021,13(6):e15619.
[10] SANER F H,BEZINOVER D.Coagulation management in liver transplantation:a never-ending story[J].Minerva Anestesiol,2018,84(9):1013-1015.
[11] RODGERS G M.Prothrombin complex concentrates in emergency bleeding disorders[J].Am J Hematol,2012,87(9):898-902.
[12] OSTERMANN H,VON HEYMANN C.Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings:efficacy and safety[J].Expert Rev Hematol,2019,12(7):525-540.
[13] DEHNE S,RIEDE C,KLOTZ R,et al.Perioperative prothrombin complex concentrate and fibrinogen administration are associated with thrombotic complications after liver transplant[J].Front Med(Lausanne),2022,9:1043674.
[14] BULUT Y,SAPRU A,ROACH G D.Hemostatic balance in pediatric acute liver failure:epidemiology of bleeding and thrombosis,physiology,and current strategies[J].Front Pediatr,2020,8:618119.
[15] HUANG W T,CANG W C,DERRY K L,et al.Four-factor prothrombin complex concentrate for coagulopathy reversal in patients with liver disease[J].Clin Appl Thromb Hemost,2017,23(8):1028-1035.
[16] TOMIĆ MAHEČIĆ T,BARONICA R,MRZLJAK A,et al.Individualized management of coagulopathy in patients with end-stage liver disease[J].Diagnostics(Basel),2022,12(12):3172. |
